Last $106.61 USD
Change Today +0.4199 / 0.40%
Volume 789.3K
JNJ On Other Exchanges
Symbol
Exchange
New York
Xetra
Mexico
Sao Paulo
Bogota
As of 10:23 AM 09/18/14 All times are local (Market data is delayed by at least 15 minutes).

johnson & johnson (JNJ) Snapshot

Open
$106.18
Previous Close
$106.19
Day High
$106.71
Day Low
$106.03
52 Week High
07/7/14 - $106.74
52 Week Low
10/9/13 - $85.50
Market Cap
300.7B
Average Volume 10 Days
5.8M
EPS TTM
$5.84
Shares Outstanding
2.8B
EX-Date
08/22/14
P/E TM
18.3x
Dividend
$2.80
Dividend Yield
2.56%
Current Stock Chart for JOHNSON & JOHNSON (JNJ)

johnson & johnson (JNJ) Details

Johnson & Johnson, together with its subsidiaries, is engaged in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The Consumer segment offers a range of products used in the baby care, skin care, oral care, wound care, and women’s health fields, as well as nutritionals, over-the-counter pharmaceutical products, and wellness and prevention platforms under the JOHNSON’S, AVEENO, CLEAN & CLEAR, DABAO, JOHNSON’S Adult, LUBRIDERM, NEUTROGENA, RoC, VENDÔME, LISTERINE, BAND-AID, NEOSPORIN, STAYFREE, CAREFREE, o.b. tampon, SPLENDA, TYLENOL, SUDAFED, ZYRTEC, MOTRIN IB, and PEPCID brand names. This segment markets its products to the general public, as well as to retail outlets and distributors. The Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, cardiovascular, contraceptive, gastrointestinal, hematology, immunology, infectious diseases, metabolic, neurology, oncology, pain management, thrombosis, and vaccines. This segment distributes its products directly to retailers, wholesalers, and health care professionals for prescription use. The Medical Devices and Diagnostics segment offers various products to treat cardiovascular disease; orthopaedic and neurological products; general surgery, biosurgical, and energy products; professional diagnostic products; infection prevention products; and disposable contact lenses. This segment distributes its products to wholesalers, hospitals, and retailers, used principally in the professional fields by physicians, nurses, hospitals, and clinics. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.

128,100 Employees
Last Reported Date: 02/21/14
Founded in 1885

johnson & johnson (JNJ) Top Compensated Officers

Chairman, Chief Executive Officer, Chairman o...
Total Annual Compensation: $1.5M
Chief Financial Officer, Vice President of Fi...
Total Annual Compensation: $842.3K
Group Worldwide Chairman and Member of Execut...
Total Annual Compensation: $2.7M
Worldwide Chairman of Pharmaceuticals, Chief ...
Total Annual Compensation: $952.9K
Vice President, General Counsel and Member of...
Total Annual Compensation: $542.3K
Compensation as of Fiscal Year 2013.

johnson & johnson (JNJ) Key Developments

Johnson & Johnson Plans to Construct Manufacturing Plant in Telangana, India

Johnson & Johnson plans to construct a manufacturing plant in Telangana, India. The factory will reportedly be operational by 2016 and up to 1,500 people will be employed at the 48-acre facility. The reported cost of establishing the plant is INR 4 billion (USD 65.6 million).

Johnson & Johnson Seeks Acquisitions

Johnson & Johnson (NYSE:JNJ) is looking for acquisitions. Dominic Caruso, Chief Financial Officer of Johnson & Johnson said, having an acquisition return lower than the cost of capital seems like a very inefficient use of capital and rather than do one major acquisition where you have that level of risk we could certainly do 10 acquisitions of smaller sizes that give you that kind of buffer of that risk or give you a portfolio approach to the acquisition that kind of gives you a sense that some will work better than others, of course, therefore you have a higher degree of probability that you will return - get a return higher than your cost of capital.

Johnson & Johnson Presents at 2014 Morgan Stanley Global Healthcare Conference, Sep-10-2014 09:45 AM

Johnson & Johnson Presents at 2014 Morgan Stanley Global Healthcare Conference, Sep-10-2014 09:45 AM. Venue: The Grand Hyatt Hotel, New York, New York, United States. Speakers: Dominic J. Caruso, Chief Financial Officer, Vice President of Finance and Member of Executive Committee.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
JNJ:US $106.65 USD +0.46

JNJ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Intel Corp $35.02 USD +0.035
International Business Machines Corp $193.54 USD +0.74
Pfizer Inc $30.54 USD +0.19
Roche Holding AG SFr.283.70 CHF +2.90
Procter & Gamble Co/The $84.32 USD +0.16
View Industry Companies
 

Industry Analysis

JNJ

Industry Average

Valuation JNJ Industry Range
Price/Earnings 19.6x
Price/Sales 4.1x
Price/Book 3.8x
Price/Cash Flow 19.3x
TEV/Sales 3.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JOHNSON & JOHNSON, please visit www.jnj.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.